Table of Contents Author Guidelines Submit a Manuscript
International Journal of Breast Cancer
Volume 2011 (2011), Article ID 967419, 12 pages
http://dx.doi.org/10.4061/2011/967419
Review Article

Multidrug Resistance in Breast Cancer: From In Vitro Models to Clinical Studies

Academic Unit of Clinical Oncology, DU10, Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK

Received 9 July 2010; Accepted 7 January 2011

Academic Editor: Emmanuelle Charafe-JaufFret

Copyright © 2011 N. S. Wind and I. Holen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [54 citations]

The following is the list of published articles that have cited the current article.

  • Preethy Prasad, Ji Cheng, Adam Shuhendler, Andrew M Rauth, and Xiao Yu Wu, “A novel nanoparticle formulation overcomes multiple types of membrane efflux pumps in human breast cancer cells.,” Drug delivery and translational research, vol. 2, no. 2, pp. 95–105, 2012. View at Publisher · View at Google Scholar
  • Arturo Aguilar-Rojas, Maira Huerta-Reyes, Guadalupe Maya-Nunez, Fabian Arechavaleta-Velasco, P. Michael Conn, Alfredo Ulloa-Aguirre, and Jesus Valdes, “Gonadotropin-releasing hormone receptor activates GTPase RhoA and inhibits cell invasion in the breast cancer cell line MDA-MB-231,” Bmc Cancer, vol. 12, 2012. View at Publisher · View at Google Scholar
  • Nicolay V. Litviakov, Nadezhda V. Cherdyntseva, Matvey M. Tsyganov, Evgeny V. Denisov, Evgeny Y. Garbukov, Marina K. Merzliakova, Victor V. Volkomorov, Sergey V. Vtorushin, Marina V. Zavyalova, Elena M. Slonimskaya, and Vladimir M. Perelmuter, “Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response,” Cancer Chemotherapy and Pharmacology, vol. 71, no. 1, pp. 153–163, 2012. View at Publisher · View at Google Scholar
  • Christopher J. B. Nicol, and Anthony J. Apostoli, “PPAR Medicines and Human Disease: The ABCs of It All,” Ppar Research, 2012. View at Publisher · View at Google Scholar
  • Gabriela Nestal de Moraes, Flavia C. Vasconcelos, Deborah Delbue, Giuliana P. Mognol, Cinthya Sternberg, Joao P. B. Viola, and Raquel C. Maia, “Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels,” European Journal of Cell Biology, vol. 92, no. 8-9, pp. 247–256, 2013. View at Publisher · View at Google Scholar
  • Ming Liu, Tingjun Hou, Zhiwei Feng, and Youyong Li, “The flexibility of P-glycoprotein for its poly-specific drug binding from molecular dynamics simulations,” Journal Of Biomolecular Structure & Dynamics, vol. 31, no. 6, pp. 612–629, 2013. View at Publisher · View at Google Scholar
  • Paulina Kucharzewska, and Mattias Belting, “Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress,” Journal of Extracellular Vesicles, vol. 2, no. 0, 2013. View at Publisher · View at Google Scholar
  • Yunshan Wang, Guangxin Ma, Qin Wang, Mingxin Wen, Yangyang Xu, Xiuquan He, Pengju Zhang, Yuli Wang, Taomei Yang, Panpan Zhan, and Guangwei Wei, “Involvement of CUL4A in Regulation of Multidrug Resistance to P-gp Substrate Drugs in Breast Cancer Cells,” Molecules, vol. 19, no. 1, pp. 159–176, 2013. View at Publisher · View at Google Scholar
  • Shanliang Zhong, Wenjing Li, Zhiyuan Chen, Jinjin Xu, and Jianhua Zhao, “miR-222 and miR-29a contribute to the drug-resistance of breast cancer cells,” Gene, vol. 531, no. 1, pp. 8–14, 2013. View at Publisher · View at Google Scholar
  • Peng Zhang, Bei-Bei Zheng, Hong-Yuan Wang, Jin-Hua Chen, Xin-Yong Liu, and Xiu-Li Guo, “ DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo ,” Journal of Pharmacy and Pharmacology, vol. 66, no. 3, pp. 398–407, 2013. View at Publisher · View at Google Scholar
  • Asmaa A. Sallam, Wael E. Houssen, Chris R. Gissendanner, Khaled Y. Orabi, Ahmed I. Foudah, and Khalid A. El Sayed, “Bioguided discovery and pharmacophore modeling of the mycotoxic indole diterpene alkaloids penitrems as breast cancer proliferation, migration, and invasion inhibitors,” Medchemcomm, vol. 4, no. 10, pp. 1360–1369, 2013. View at Publisher · View at Google Scholar
  • Francesca Greco, Inam Arif, Ruth Botting, Cristina Fante, Luigi Quintieri, Chiara Clementi, Oddone Schiavon, and Gianfranco Pasut, “Polysialic acid as a drug carrier: evaluation of a new polysialic acid–epirubicin conjugate and its comparison against established drug carriers,” Polymer Chemistry, vol. 4, no. 5, pp. 1600, 2013. View at Publisher · View at Google Scholar
  • Asmaa A Sallam, Nehad M Ayoub, Ahmed I Foudah, Chris R Gissendanner, Sharon A Meyer, and Khalid A El Sayed, “Indole diterpene alkaloids as novel inhibitors of the Wnt/β-catenin pathway in breast cancer cells.,” European journal of medicinal chemistry, vol. 70, pp. 594–606, 2013. View at Publisher · View at Google Scholar
  • Marwan El-Sabban, Khaled Ghattass, and Rana Assah, “Targeting Hypoxia for Sensitization of Tumors to Radio- and Chemotherapy,” Current Cancer Drug Targets, vol. 13, no. 6, pp. 670–685, 2013. View at Publisher · View at Google Scholar
  • Yoonseok Kam, Tuhin Das, Haibin Tian, Parastou Foroutan, Epifanio Ruiz, Gary Martinez, Susan Minton, Robert J. Gillies, and Robert A. Gatenby, “Sweat but no gain: Inhibiting proliferation of multidrug resistant cancer cells with “ersatzdroges”,” International Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • Huiyuan Wang, Feng Li, Chengan Du, Huixin Wang, Ram I. Mahato, and Yongzhuo Huang, “Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer,” Molecular Pharmaceutics, vol. 11, no. 8, pp. 2600–2611, 2014. View at Publisher · View at Google Scholar
  • Tan-Boon Toh, Dong-Keun Lee, Weixin Hou, Lissa Nurrul Abdullah, J Jacqueline Nguyen, Dean Ho, and Edward Kai-Hua Chow, “Nanodiamond-Mitoxantrone Complexes Enhance Drug Retention in Chemoresistant Breast Cancer Cells,” Molecular Pharmaceutics, vol. 11, no. 8, pp. 2683–2691, 2014. View at Publisher · View at Google Scholar
  • Yoonseok Kam, Tuhin Das, Susan Minton, and Robert A Gatenby, “Evolutionary strategy for systemic therapy of metastatic breast cancer: balancing response with suppression of resistance,” Women's Health, vol. 10, no. 4, pp. 423–430, 2014. View at Publisher · View at Google Scholar
  • Meena Mahmood, Thikra Mustafa, Yang Xu, Zeid Nima, Ganesh Kannarpady, Shawn Bourdo, Daniel Casciano, and Alexandru S Biris, “Calcium-channel blocking and nanoparticles-based drug delivery for treatment of drug-resistant human cancers,” Therapeutic Delivery, vol. 5, no. 7, pp. 763–780, 2014. View at Publisher · View at Google Scholar
  • Paula C. Pohl, Danielle D. Carvalho, Sirlei Daffre, Itabajara da Silva Vaz Jr, and Aoi Masuda, “In vitro establishment of ivermectin-resistant Rhipicephalus microplus cell line and the contribution of ABC transporters on the resistance mechanism,” Veterinary Parasitology, 2014. View at Publisher · View at Google Scholar
  • Ahmed I. Foudah, Asmaa A. Sallam, Mohamed R. Akl, and Khalid A. El Sayed, “Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors,” European Journal of Medicinal Chemistry, vol. 73, pp. 310–324, 2014. View at Publisher · View at Google Scholar
  • Yiyi Liu, Quanquan Gu, Jack P. Hou, Jiawei Han, and Jian Ma, “A network-assisted co-clustering algorithm to discover cancer subtypes based on gene expression,” Bmc Bioinformatics, vol. 15, 2014. View at Publisher · View at Google Scholar
  • Ahmed Malki, Rasha Y. Elbayaa, Hayam M.A. Ashour, Christopher A. Loffredo, and Amal M. Youssef, “Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling,” Journal of Enzyme Inhibition and Medicinal Chemistry, pp. 1–10, 2014. View at Publisher · View at Google Scholar
  • Shanliang Zhong, Tengfei Ma, Xiaohui Zhang, Mengmeng Lv, Lin Chen, Jinhai Tang, and Jianhua Zhao, “MicroRNA expression profiling and bioinformatics analysis of dysregulated microRNAs in vinorelbine-resistant breast cancer cells,” Gene, 2014. View at Publisher · View at Google Scholar
  • S Essex, G Navarro, P Sabhachandani, A Chordia, M Trivedi, S Movassaghian, and V P Torchilin, “Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors,” Gene Therapy, 2014. View at Publisher · View at Google Scholar
  • Anna-Maria Katsori, and Dimitra Hadjipavlou-Litina, “Coumarin derivatives: an updated patent review (2012 – 2014),” Expert Opinion on Therapeutic Patents, pp. 1–25, 2014. View at Publisher · View at Google Scholar
  • Khaled Ghattass, Sally El-Sitt, Kazem Zibara, Saide Rayes, Makhluf J. Haddadin, Marwan El-Sabban, and Hala Gali-Muhtasib, “The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway,” Molecular Cancer, vol. 13, 2014. View at Publisher · View at Google Scholar
  • Yunliang Chen, Michael Scully, Gloria Petralia, and Ajay Kakkar, “Binding and inhibition of drug transport proteins by heparin A potential drug transporter modulator capable of reducing multidrug resistance in human cancer cells,” Cancer Biology & Therapy, vol. 15, no. 1, pp. 135–145, 2014. View at Publisher · View at Google Scholar
  • Melva Louisa, Tjahjani Mirawati Soediro, and Frans Dhyanagiri Suyatna, “in vitro Modulation of P-glycoprotein, MRP-1 and BCRP Expression by Mangiferin in Doxorubicin-Treated MCF-7 Cells,” Asian Pacific Journal of Cancer Prevention, vol. 15, no. 4, pp. 1639–1642, 2014. View at Publisher · View at Google Scholar
  • Heather L. Martin, Laura Smith, and Darren C. Tomlinson, “Multidrug-resistant breast cancer: Current perspectives,” Breast Cancer: Targets and Therapy, vol. 6, no. 0, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • Alessia Carta, Rachel Chetcuti, and Duncan Ayers, “An Introspective Update on the Influence of miRNAs in Breast Carcinoma and Neuroblastoma Chemoresistance,” Genetics Research International, vol. 2014, pp. 1–13, 2014. View at Publisher · View at Google Scholar
  • M. Kamil Hussain, M. Imran Ansari, N. Yadav, Puneet K. Gupta, A. K. Saxena, K. Hajela, J. Gautam, Ruchir Kant, P. R. Maulik, R. Trivedi, A. Dwivedi, K. Ravi Kumar, A. K. Gupta, R. Saxena, I. Fatima, M. Manohar, P. Kushwaha, and V. Khedgikar, “Design and synthesis of ERα/ERβ selective coumarin and chromene derivatives as potential anti-breast cancer and anti-osteoporotic agents,” RSC Advances, vol. 4, no. 17, pp. 8828, 2014. View at Publisher · View at Google Scholar
  • Vaibhav Mundra, Wei Li, and Ram I Mahato, “Nanoparticle-mediated drug delivery for treating melanoma,” Nanomedicine, pp. 1–21, 2015. View at Publisher · View at Google Scholar
  • Nadia Picot, Roxann Guerrette, Annie-Pier Beauregard, Stéphanie Jean, Pascale Michaud, Jason Harquail, Sami Benzina, and Gilles A. Robichaud, “Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs,” Molecular Carcinogenesis, 2015. View at Publisher · View at Google Scholar
  • Jian Wen, Syn Yeo, Chenran Wang, Song Chen, Shaogang Sun, Michael A. Haas, Wei Tu, Feng Jin, and Jun-Lin Guan, “Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptos,” Breast Cancer Research And Treatment, vol. 149, no. 3, pp. 619–629, 2015. View at Publisher · View at Google Scholar
  • Pedro M. Enriquez-Navas, Jonathan W. Wojtkowiak, and Robert A. Gatenby, “Application of Evolutionary Principles to Cancer Therapy,” Cancer Research, vol. 75, no. 22, pp. 4675–4680, 2015. View at Publisher · View at Google Scholar
  • Panagiotis Apostolou, Maria Toloudi, and Ioannis Papasotiriou, “Identification of genes involved in breast cancer and breast cancer stem cells.,” Breast cancer (Dove Medical Press), vol. 7, pp. 183–91, 2015. View at Publisher · View at Google Scholar
  • Natália Aniceto, Alex A. Freitas, Andreas Bender, and Taravat Ghafourian, “Simultaneous Prediction of four ATP-binding Cassette Transporters’ Substrates Using Multi-label QSAR,” Molecular Informatics, 2016. View at Publisher · View at Google Scholar
  • Nagendra S. Singh, Michel Bernier, and Irving W. Wainer, “Selective GPR55 antagonism reduces chemoresistance in cancer cells,” Pharmacological Research, 2016. View at Publisher · View at Google Scholar
  • Yuan Tang, Yue Wang, Mohammad F. Kiani, and Bin Wang, “Classification, treatment strategy and associated drug resistance in breast cancer,” Clinical Breast Cancer, 2016. View at Publisher · View at Google Scholar
  • Marike W. van Gisbergen, Marcus Cebula, Jie Zhang, Astrid Ottosson-Wadlund, Ludwig Dubois, Philippe Lambin, Kenneth D. Tew, Danyelle M. Townsend, Guido R. M. M. Haenen, Marie-José Drittij-Reijnders, Hisao Saneyoshi, Mika Araki, Yuko Shishido, Yoshihiro Ito, Elias S. J. Arnér, Hiroshi Abe, Ralf Morgenstern, and Katarina Johansson, “Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells,” Molecular Pharmaceutics, 2016. View at Publisher · View at Google Scholar
  • Jen-Tsan Chi, Jhih-Pu Syu, and Hsiu-Ni Kung, “Nrf2 is the key to chemotherapy resistance in MCF7 breast cancer cells under hypoxia,” Oncotarget, vol. 7, no. 12, pp. 14659–14672, 2016. View at Publisher · View at Google Scholar
  • Vanessa Lopes-Rodrigues, Alessio Di Luca, Diana Sousa, Hugo Seca, Paula Meleady, Michael Henry, Raquel T. Lima, Robert O'Connor, and M. Helena Vasconcelos, “Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells,” Biochimica et Biophysica Acta (BBA) - General Subjects, vol. 1860, no. 3, pp. 618–627, 2016. View at Publisher · View at Google Scholar
  • Nikolai V Litviakov, Nadezhda V Cherdyntseva, Matvey M Tsyganov, Elena M Slonimskaya, Marina K Ibragimova, Polina V Kazantseva, Julia Kzhyshkowska, and Eugeniy L Choinzonov, “Deletions of multidrug resistance gene loci in breast cancer leads to the down-regulation of its expression and predict tumor response to neoadjuvant chemotherapy.,” Oncotarget, vol. 7, no. 7, pp. 7829–41, 2016. View at Publisher · View at Google Scholar
  • Ahmed Malki, Mona Mohsen, Hassan Aziz, Ola Rizk, Omima Shaban, Mohamed El-Sayed, Zaki Sherif, and Hayam Ashour, “New 3-Cyano-2-Substituted Pyridines Induce Apoptosis in MCF 7 Breast Cancer Cells,” Molecules, vol. 21, no. 2, pp. 230, 2016. View at Publisher · View at Google Scholar
  • Tito A. Sandoval, Claudia P. Urueña, Mónica Llano, Alejandra Gómez-Cadena, John F. Hernández, Luis Gonzalo Sequeda, Alix E. Loaiza, Alfonso Barreto, Shaoping Li, and Susana Fiorentino, “ Standardized Extract from Caesalpinia spinosa is Cytotoxic Over Cancer Stem Cells and Enhance Anticancer Activity of Doxorubicin ,” The American Journal of Chinese Medicine, pp. 1–25, 2016. View at Publisher · View at Google Scholar
  • Dan-dan Wang, Su-jin Yang, Xiu Chen, Hong-Yu Shen, Long-ji Luo, Xiao-hui Zhang, Shan-liang Zhong, Jian-hua Zhao, and Jin-hai Tang, “miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27kip1 pathway,” Tumor Biology, 2016. View at Publisher · View at Google Scholar
  • Mehvash Zaki, Farukh Arjmand, and Sartaj Tabassum, “Current and Future potential of metallo drugs: revisiting DNA–binding of metal containing molecules and their diverse mechanism of action,” Inorganica Chimica Acta, 2016. View at Publisher · View at Google Scholar
  • Aryan Stanley, G. Hossein Ashrafi, Alan M. Seddon, and Helmout Modjtahedi, “Synergistic effects of various Her inhibitors in combination with IGF-1R, C-MET and Src targeting agents in breast cancer cell lines,” Scientific Reports, vol. 7, no. 1, 2017. View at Publisher · View at Google Scholar
  • Huangyu Jiang, Jia Yu, Haihui Zheng, Jiamei Chen, Jinjun Wu, Xiaoxiao Qi, Ying Wang, Xinchun Wang, Ming Hu, Lijun Zhu, and Zhongqiu Liu, “Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Regulate the Disposition of Acacetin Glucuronides,” Pharmaceutical Research, 2017. View at Publisher · View at Google Scholar
  • Yiping Zeng, Zhangyou Yang, Hong Li, Yuhui Hao, Cong Liu, Lin Zhu, Jing Liu, Binghui Lu, and Rong Li, “Multifunctional Nanographene Oxide for Targeted Gene-Mediated Thermochemotherapy of Drug-resistant Tumour,” Scientific Reports, vol. 7, pp. 43506, 2017. View at Publisher · View at Google Scholar
  • Tao Qin, Gena Huang, Liyuan Chi, Silei Sui, Chen Song, Na Li, Siwen Sun, Ning Li, Min Zhang, Zuowei Zhao, Lianhong Li, and Man Li, “Exceptionally high UBE2C expression is a unique phenomenon in basal-like type breast cancer and is regulated by BRCA1,” Biomedicine & Pharmacotherapy, vol. 95, pp. 649–655, 2017. View at Publisher · View at Google Scholar
  • João Marcos de Azevedo Delou, Rosane Vianna-Jorge, Giselle Maria Vignal, Vanessa Índio-do-Brasil, Maria Theresa de Souza Accioly, Taiana Sousa Lopes da Silva, Diogo Nascimento Piranda, Marcelo Sobral-Leite, Marcelo Alex de Carvalho, and Márcia Alves Marques Capella, “Loss of constitutive ABCB1 expression in breast cancer associated with worse prognosis.,” Breast cancer (Dove Medical Press), vol. 9, pp. 415–428, 2017. View at Publisher · View at Google Scholar
  • Di Wu, Mengjie Si, Hui-Yi Xue, and Ho-Lun Wong, “Nanomedicine applications in the treatment of breast cancer: current state of the art.,” International journal of nanomedicine, vol. 12, pp. 5879–5892, 2017. View at Publisher · View at Google Scholar